BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25854936)

  • 21. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
    Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
    Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
    World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients.
    Iannitto E; Ambrosetti A; Ammatuna E; Colosio M; Florena AM; Tripodo C; Minardi V; Calvaruso G; Mitra ME; Pizzolo G; Menestrina F; Franco V
    Cancer; 2004 Nov; 101(9):2050-7. PubMed ID: 15389479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of Upfront Therapy for Marginal Zone Lymphoma.
    Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis.
    Dungarwalla M; Appiah-Cubi S; Kulkarni S; Saso R; Wotherspoon A; Osuji N; Swansbury J; Cunningham DC; Catovsky D; Dearden CE; Matutes E
    Br J Haematol; 2008 Oct; 143(1):71-4. PubMed ID: 18671706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
    Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
    Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Splenic marginal zone lymphoma].
    Dimopoulos K; Pedersen M
    Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up.
    Cervetti G; Galimberti S; Pelosini M; Ghio F; Cecconi N; Petrini M
    Ann Oncol; 2013 Sep; 24(9):2434-8. PubMed ID: 23712547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes.
    Iannitto E; Minardi V; Calvaruso G; Ammatuna E; Florena AM; Mulè A; Tripodo C; Quintini G; Abbadessa V
    Eur J Haematol; 2005 Aug; 75(2):130-5. PubMed ID: 16000129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases.
    Cervetti G; Ghio F; Cecconi N; Morganti R; Galimberti S; Petrini M
    J Chemother; 2017 Apr; 29(2):126-129. PubMed ID: 27454143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016).
    Florindez JA; Alderuccio JP; Reis IM; Lossos IS
    Cancer; 2020 Nov; 126(21):4706-4716. PubMed ID: 32767702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Kontopidou FN; Yiakoumis X; Kokoris SI; Dimitriadou EM; Dimopoulou MN; Moschogiannis M; Korkolopoulou P; Kyrtsonis MC; Siakantaris MP; Papadaki T; Tsaftaridis P; Plata E; Papadaki HE; Vassilakopoulos TP
    Oncologist; 2013; 18(2):190-7. PubMed ID: 23345547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
    Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
    Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.